ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5,1,Headache,Headaches NEC,Headaches,Nerv,N
5,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
7,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
8,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
8,3,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,Y
8,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8,5,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
9,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
10,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
12,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
13,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
14,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
15,1,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
16,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
16,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
16,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
18,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
18,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
19,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
20,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
22,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
23,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
25,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
26,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
26,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
28,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
28,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
29,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
30,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
30,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
31,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
31,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
31,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
32,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
33,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
33,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
33,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
33,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
33,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
33,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
34,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
34,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
34,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
34,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
34,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
35,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
37,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
37,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
37,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
38,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
38,2,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
38,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
39,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
40,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
41,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
42,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
43,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
44,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
44,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
44,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
45,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
45,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
46,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
47,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
47,2,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
48,1,Coronary artery embolism,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
49,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
50,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
51,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
52,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
52,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
53,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
54,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
55,1,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
56,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
57,2,Colonic abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
57,3,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
58,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
59,1,Headache,Headaches NEC,Headaches,Nerv,N
60,1,Headache,Headaches NEC,Headaches,Nerv,N
60,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
61,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
62,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
63,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
64,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
65,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
66,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
67,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
67,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
68,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
69,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
70,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
71,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
71,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
71,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
71,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
71,5,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
72,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
73,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
73,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
74,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
75,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
75,3,Headache,Headaches NEC,Headaches,Nerv,N
75,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
77,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
77,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
77,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
78,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
78,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
78,3,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
78,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
78,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
79,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
79,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
79,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
80,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
80,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
81,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
82,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
83,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
84,1,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
84,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,Y
84,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
85,1,Leukoderma,Hypopigmentation disorders,Pigmentation disorders,Skin,N
86,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
86,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
87,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
87,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
87,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
88,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
88,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
89,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
89,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
90,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
90,2,Myopathy,Myopathies,Muscle disorders,Musc,N
91,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
92,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
92,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
93,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
94,1,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
95,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
95,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
95,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
95,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
95,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
95,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
95,7,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
95,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
95,9,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
95,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,11,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
95,12,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
95,13,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
95,14,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
95,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
95,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
96,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
97,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
99,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
100,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
101,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
102,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
103,1,Myopathy,Myopathies,Muscle disorders,Musc,N
104,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
105,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
106,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
107,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
108,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
109,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
109,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
109,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
110,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
110,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
111,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
112,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
112,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
112,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
113,1,Myopathy,Myopathies,Muscle disorders,Musc,N
114,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
115,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
116,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
116,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
116,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
116,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
117,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
117,2,Headache,Headaches NEC,Headaches,Nerv,N
117,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
118,1,Increased insulin requirement,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
119,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
120,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
121,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
122,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
123,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
123,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
123,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
124,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
125,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
126,1,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
127,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
128,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
129,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
129,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
129,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
130,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
131,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
132,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
133,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
134,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
136,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
137,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
138,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
138,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
139,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
140,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
141,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
141,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
142,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
143,1,Acquired hydrocele,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
143,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
144,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
144,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
144,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
145,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
146,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
146,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
147,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
147,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
147,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
148,1,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
149,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
149,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
149,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
150,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
151,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
151,2,Headache,Headaches NEC,Headaches,Nerv,N
151,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
152,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
152,2,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
152,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
152,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
152,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
152,6,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
152,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
152,8,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
152,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
152,10,Splinter haemorrhages,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
153,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
154,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
155,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
156,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
157,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
158,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
159,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
160,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
160,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
161,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
162,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
162,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
162,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
162,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
162,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
163,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
163,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
163,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
164,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
165,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
166,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
166,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
167,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
168,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
168,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
168,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
168,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
169,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
169,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
170,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
172,1,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
173,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
174,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
175,1,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
175,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
176,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
176,2,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
176,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
177,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
178,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
179,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
179,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
179,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
179,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
179,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
180,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
180,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
181,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
182,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
183,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
183,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
184,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
185,1,Meniere's disease,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
186,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
186,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
186,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
187,1,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
187,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
188,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
189,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
190,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
190,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
191,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
191,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
192,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
193,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
194,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
195,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
195,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
196,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
196,2,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
197,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
198,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
198,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
199,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
199,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
200,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
201,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
201,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
202,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
203,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
204,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
205,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
205,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
206,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
207,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
208,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
209,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
209,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
209,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
210,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
210,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
211,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
212,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
213,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
213,2,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
214,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
215,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
215,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
215,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
215,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
216,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
217,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
218,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
219,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
219,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
219,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
220,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
221,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
221,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
222,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
222,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
222,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
223,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
224,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
225,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
226,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
227,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
228,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
228,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
229,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
230,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
231,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
232,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
233,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
234,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
235,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
235,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
236,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
237,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
237,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
237,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
237,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
238,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
238,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
238,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
239,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
239,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
240,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
240,2,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
241,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
242,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
243,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
244,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
244,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
245,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
246,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
247,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
248,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
249,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
250,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
250,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
251,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
252,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
252,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
252,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
253,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
253,2,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
254,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
255,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
255,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
255,3,Headache,Headaches NEC,Headaches,Nerv,N
255,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
256,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
256,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
257,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
258,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
258,2,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
259,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
260,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
261,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
262,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
263,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
263,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
263,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
264,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
265,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
266,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
267,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
267,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
268,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
269,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
269,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
269,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
269,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
270,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
270,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
271,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
271,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
272,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
272,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
272,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
273,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
273,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
273,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
274,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
274,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
275,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
276,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
277,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
278,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
279,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
279,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
280,1,Headache,Headaches NEC,Headaches,Nerv,N
280,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
281,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
282,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
283,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
284,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
285,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
285,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
286,1,Headache,Headaches NEC,Headaches,Nerv,N
286,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
286,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
286,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
287,1,Arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
287,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
288,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
289,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
290,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
291,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
292,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
292,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
293,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
294,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
295,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
295,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
295,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
296,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
297,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
298,1,Headache,Headaches NEC,Headaches,Nerv,N
298,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
299,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
300,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
300,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
300,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
300,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
300,5,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
301,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
302,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
302,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
303,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
303,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
303,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
303,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
303,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
303,6,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
303,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
304,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
304,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
304,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
304,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
305,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
305,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
306,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
307,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
308,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
308,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
309,1,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
309,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
310,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
310,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
311,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
312,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
312,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
312,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
314,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
315,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
316,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
317,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
318,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
319,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
320,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
320,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
321,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
322,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
322,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
323,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
324,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
325,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
326,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
326,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
327,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
328,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
329,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
329,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
329,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
330,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
330,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
331,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
331,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
332,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
333,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
333,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
334,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
334,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
335,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
335,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
335,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
336,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
337,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
338,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
339,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
340,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
341,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
342,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
343,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
344,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
344,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
344,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
345,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
346,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
347,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
348,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
349,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
350,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
350,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
350,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
351,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
352,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
353,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
354,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
355,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
356,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
356,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,3,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
356,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
357,1,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,Y
357,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
358,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
359,1,Adams-Stokes syndrome,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
360,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
361,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
362,1,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
363,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
364,1,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
364,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
365,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
366,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
366,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
366,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
366,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
367,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
368,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
368,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
369,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
369,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
369,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
370,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
370,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
370,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
370,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
371,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
371,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
371,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
372,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
373,1,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
374,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
375,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
375,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
375,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
375,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
375,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
376,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
377,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
378,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
379,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
380,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
381,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
382,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
383,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
384,1,Adenocarcinoma gastric,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
384,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
384,3,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
385,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
386,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
386,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
386,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
387,1,Lymphangitis,Vascular infections,Infections - pathogen unspecified,Infec,N
388,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
388,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
389,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
390,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
391,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
391,2,Headache,Headaches NEC,Headaches,Nerv,N
392,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
393,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
393,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
393,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
393,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
394,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
394,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
394,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
395,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
396,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
397,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
397,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
398,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
399,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
400,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
400,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
401,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
401,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
402,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
403,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
404,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
404,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
405,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,Y
405,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
405,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
405,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
405,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
405,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
405,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
406,1,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
407,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
408,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
409,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
410,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
410,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
410,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
410,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
411,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
412,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
413,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
414,1,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
415,1,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
415,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
416,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
417,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
417,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
417,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
418,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
419,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
420,1,Headache,Headaches NEC,Headaches,Nerv,N
421,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
421,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
422,1,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
423,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
424,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
425,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
425,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
425,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
426,1,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
427,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
428,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
429,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
429,2,Rash follicular,Pustular conditions,Epidermal and dermal conditions,Skin,N
430,1,Hysterical psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
431,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
431,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
432,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
433,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
434,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
435,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
436,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
437,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
438,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
438,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
438,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
439,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
439,2,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
440,1,Headache,Headaches NEC,Headaches,Nerv,N
440,2,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
440,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
441,1,Injection site thrombosis,Injection site reactions,Administration site reactions,Genrl,N
442,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
443,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
444,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
444,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
445,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
445,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
445,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
445,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
446,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
446,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
447,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
448,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
449,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
449,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
449,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
450,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
451,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
452,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
452,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
453,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
453,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
453,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
453,4,Headache,Headaches NEC,Headaches,Nerv,N
453,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
453,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
453,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
454,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
454,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
455,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
456,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
456,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
457,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
458,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
458,2,Headache,Headaches NEC,Headaches,Nerv,N
458,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
458,4,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
458,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
459,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
459,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
459,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
459,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
459,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
460,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
461,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
461,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
461,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
462,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
463,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
463,2,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
463,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
463,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
464,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
464,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
464,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
465,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
465,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
466,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
466,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
466,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
467,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
467,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
467,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
468,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
469,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
469,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
470,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
470,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
470,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
470,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
470,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
471,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
472,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
472,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
473,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
473,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
474,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
474,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
475,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
476,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
476,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
477,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
477,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
477,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
478,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
478,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
478,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
478,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
479,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
479,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
480,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
480,2,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
481,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
482,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
483,1,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
484,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
484,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
484,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
484,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
485,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
485,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
486,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
487,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
488,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
488,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
489,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
490,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
490,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
490,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
490,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
491,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
492,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
493,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
494,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
494,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
495,1,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
496,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
496,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
496,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
496,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
497,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
497,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
497,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
497,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
498,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
499,1,Carditis,Cardiac infections and inflammations NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
500,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
500,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
500,3,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
500,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
501,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
502,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
503,1,Disability,Disability issues,Lifestyle issues,SocCi,N
503,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
504,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
504,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
504,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
505,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
505,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
505,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
506,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
507,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
507,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
508,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
508,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
508,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
508,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
509,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
510,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
510,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
510,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
510,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
510,5,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
510,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
510,7,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
510,8,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
510,9,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
510,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
510,11,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
510,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
510,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
511,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
511,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
511,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
511,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
511,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
511,6,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
512,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
512,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
512,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
512,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
512,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
512,6,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
512,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
513,1,Chronic lymphocytic leukaemia transformation,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
513,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
513,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
513,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
513,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
514,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
514,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
514,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
514,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
514,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
515,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
515,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
515,3,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
515,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
516,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
516,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
517,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
517,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
517,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
517,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
518,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
518,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
518,3,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
519,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
519,2,Headache,Headaches NEC,Headaches,Nerv,N
519,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
520,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
520,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
520,3,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
520,4,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
520,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
521,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
521,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
522,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
522,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
522,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
523,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
523,2,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
524,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
524,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
524,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
525,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
525,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
526,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
526,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
526,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
526,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
527,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
527,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
527,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
528,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
528,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
528,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
528,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
528,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
529,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
529,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
529,3,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
529,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
529,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
529,6,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
529,7,Carbon dioxide decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
529,8,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
529,9,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
529,10,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
529,11,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
529,12,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
529,13,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
529,14,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
530,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
530,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
530,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
530,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
531,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
531,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
531,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
531,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
532,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
532,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
532,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
532,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
533,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
533,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
533,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
533,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
534,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
535,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
535,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
535,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
536,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
536,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
536,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
537,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
538,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
538,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
538,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
538,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
539,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
539,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
539,3,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
539,4,Neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
539,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
540,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
540,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
540,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
541,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
542,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
542,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
542,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
543,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
543,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
544,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
544,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
545,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
545,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
545,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
546,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
546,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
546,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
547,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
547,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
547,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
547,4,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
548,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
548,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
548,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
548,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
548,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
548,6,Headache,Headaches NEC,Headaches,Nerv,N
548,7,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
549,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
549,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
550,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
551,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
552,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
553,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
553,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
554,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
554,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
555,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
556,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
556,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
557,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
557,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
557,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
557,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
557,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
558,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
558,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
559,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
559,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
560,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
560,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
560,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
561,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
562,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
562,2,Osteosclerosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
563,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
563,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
563,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
563,4,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
563,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
564,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
564,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
565,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
566,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
567,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
568,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
569,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
570,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
570,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
570,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
571,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
572,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
573,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
573,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
574,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
574,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
574,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
574,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
574,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
574,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
574,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
574,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
574,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
575,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
576,1,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
577,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
577,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
577,3,Plantar fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
577,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
578,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
578,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
578,3,Headache,Headaches NEC,Headaches,Nerv,N
578,4,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
578,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
578,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
579,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
580,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
581,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
581,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
581,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
581,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
581,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
582,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
582,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
582,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
583,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
584,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
584,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
584,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
585,1,Renal necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
586,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
587,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
588,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
589,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
590,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
590,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
590,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
590,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
591,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
591,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
592,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
592,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
592,3,Non-cardiogenic pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
593,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
593,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
593,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
594,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
594,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
594,3,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
594,4,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
594,5,Epstein-Barr virus antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
595,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
595,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
596,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
597,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
597,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
598,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
598,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
598,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
599,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
599,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
599,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
600,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
601,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
601,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
602,1,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
602,2,Bursitis infective staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
602,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
602,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
602,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
603,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
603,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
603,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
604,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
605,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
605,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
606,1,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
606,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
607,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
608,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
608,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
608,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
608,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
609,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
609,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
610,1,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
610,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
610,3,Disability,Disability issues,Lifestyle issues,SocCi,N
610,4,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
610,5,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
610,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
610,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
610,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
610,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
610,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
610,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
611,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
611,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
611,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
612,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
612,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
612,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
613,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
613,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
613,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
613,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
613,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
614,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
615,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
616,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
616,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
616,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
616,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
616,5,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
616,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
616,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
616,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
616,9,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
616,10,Headache,Headaches NEC,Headaches,Nerv,N
616,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
616,12,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
616,13,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
616,14,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
617,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
617,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
617,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
617,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
617,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
618,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
618,2,Aneurysm ruptured,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
618,3,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
618,4,Arterial disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
618,5,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
618,6,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
618,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
618,8,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
618,9,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
618,10,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
618,11,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
618,12,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
618,13,Lung transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
618,14,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
618,15,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
618,16,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
618,17,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
618,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
618,19,Splenic artery aneurysm,Gastrointestinal vascular malformations,Gastrointestinal vascular conditions,Gastr,N
619,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
619,2,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
619,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
619,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
619,5,Vascular insufficiency,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
619,6,Vascular insufficiency,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
620,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
620,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
620,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
620,4,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
621,1,Renal necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
622,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
623,1,Pelvic kidney,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
623,2,Single functional kidney,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
624,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
624,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
624,3,Sciatic nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
624,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
625,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
625,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
626,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
627,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,Y
627,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
627,3,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
627,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
627,5,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
627,6,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
627,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
628,1,Complex regional pain syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
628,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
629,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
629,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
630,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
631,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
631,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
631,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
631,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
632,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
632,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
633,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
634,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
635,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
636,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
636,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
637,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
638,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
639,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
640,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
641,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
642,1,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
643,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
644,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
645,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
645,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
646,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
647,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
647,2,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
647,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
647,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
647,5,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
647,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
647,7,Vitreous abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
647,8,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
648,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
648,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
649,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
650,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
650,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
650,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
650,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
650,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
651,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
652,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
652,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
653,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
653,2,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
653,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
653,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
653,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
653,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
654,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
654,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
654,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
654,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
654,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
654,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
654,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
654,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
655,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
656,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
656,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
656,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
656,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
656,5,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
656,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
656,7,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
656,8,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
656,9,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
657,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
657,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
657,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
658,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
658,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
658,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
658,4,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
659,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
660,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
660,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
660,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
660,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
661,1,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
661,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
661,3,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
661,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
662,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
662,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
662,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
662,4,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
662,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
662,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
663,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
663,2,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
663,3,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
663,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
663,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
663,6,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
663,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
663,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
664,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
665,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
665,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
665,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
666,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
666,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
666,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
666,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
666,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
667,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
667,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
667,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
667,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
667,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
668,1,Cleft lip and palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
668,2,Teratogenicity,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
669,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
669,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
670,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
670,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
671,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
671,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
672,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
673,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
673,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
673,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
674,1,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
675,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
676,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
677,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
677,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
678,1,Chronic lymphocytic leukaemia recurrent,Leukaemias chronic lymphocytic,Leukaemias,Neopl,Y
678,2,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
678,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
679,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
679,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
679,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
680,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
680,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
680,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
680,4,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
680,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
681,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
681,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
682,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
682,2,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
682,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
682,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
682,5,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
682,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
683,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
683,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
684,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
685,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
686,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
687,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
688,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
688,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
689,1,Acute left ventricular failure,Left ventricular failures,Heart failures,Card,N
690,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
690,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
691,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
691,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
692,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
692,2,Bronchostenosis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
692,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
692,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
692,5,Nasal septum disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
692,6,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
692,7,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
693,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
693,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
693,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
693,4,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
693,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
694,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
694,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,Y
695,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
695,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
696,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
697,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
698,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
698,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,Y
699,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
699,2,Arteriovenous fistula,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
699,3,Bone marrow oedema,Haematological disorders,Haematological disorders NEC,Blood,N
699,4,Bone metabolism disorder,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
699,5,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
700,1,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
700,2,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
700,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
700,4,Fungal peritonitis,Fungal infections NEC,Fungal infectious disorders,Infec,N
700,5,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
700,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
700,7,Peritoneal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
700,8,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
700,9,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
701,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
701,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
702,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
703,1,Psychotic disorder due to a general medical condition,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
704,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
705,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
705,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
706,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
707,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
708,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
708,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
708,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
708,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
709,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
709,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
709,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
709,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
709,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
710,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
710,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
711,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
711,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
712,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
713,1,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
714,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
714,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
714,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
714,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
714,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
714,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
714,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
715,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
716,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
717,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
718,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
719,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
719,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
719,3,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
719,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
720,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
721,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
721,2,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
721,3,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
721,4,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
722,1,Headache,Headaches NEC,Headaches,Nerv,N
722,2,Intracranial hypotension,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
722,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
722,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
722,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
723,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
723,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
723,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
724,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
724,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
724,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
725,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
725,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
725,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
726,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
727,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
727,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
727,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
727,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
727,5,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
727,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
727,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
728,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
729,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
729,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
729,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
729,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
730,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
731,1,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
731,2,Migraine,Migraine headaches,Headaches,Nerv,N
731,3,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
731,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
732,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
732,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
733,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
733,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
733,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
734,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
735,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
735,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
736,1,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
736,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
736,3,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
736,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
737,1,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
737,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
738,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
738,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
738,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
739,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
739,2,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
739,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
740,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
741,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
741,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
742,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
743,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
744,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
744,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
744,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
744,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
745,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
745,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
745,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
745,4,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
745,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
746,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
747,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
747,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
747,3,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
747,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
747,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
748,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
749,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
750,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
751,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
752,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
753,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
753,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
753,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
753,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
753,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
753,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
753,7,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
753,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
753,9,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
753,10,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
754,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
754,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
754,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
754,4,Hypertensive crisis,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
754,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
754,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
754,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
754,8,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
754,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
755,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
756,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
757,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
758,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
759,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
759,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
760,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
760,2,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
761,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
761,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
762,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
763,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
764,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
765,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
766,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
767,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
768,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
768,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
768,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
768,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
769,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
769,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
770,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
771,1,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
772,1,Meningitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
773,1,Allodynia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
773,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
773,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
773,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
773,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
773,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
773,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
773,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
773,9,Hypoglossal nerve paralysis,Hypoglossal nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
773,10,IVth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
773,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
774,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
774,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
775,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
776,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
776,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
776,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
776,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
777,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
777,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
777,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
777,4,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
778,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
779,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
780,1,Acinetobacter test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,Y
781,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
781,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
781,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
781,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
781,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
781,6,Tongue injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
782,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
782,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
783,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
783,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
783,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
784,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
785,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
785,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
785,3,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
785,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
785,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
786,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,Y
787,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
787,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
787,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
788,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
788,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
788,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
788,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
788,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
789,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
790,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
790,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
790,3,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
790,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
790,5,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
791,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
791,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
791,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
791,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
791,5,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
792,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
792,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
792,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
792,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
792,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
792,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
792,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
792,8,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
792,9,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
792,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
792,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
792,12,Peripheral T-cell lymphoma unspecified recurrent,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
792,13,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
792,14,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
792,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
793,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
794,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
794,2,Bladder dysfunction,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
794,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
794,4,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
794,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
794,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
794,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
794,8,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
795,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
796,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
796,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
797,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
797,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
798,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
798,2,Necrotising herpetic retinopathy,Herpes viral infections,Viral infectious disorders,Infec,N
798,3,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
799,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
799,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
800,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
800,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
800,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
800,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
800,5,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
801,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
802,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
802,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
802,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
802,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
803,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
803,2,Lumbosacral radiculoplexus neuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
803,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
804,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
804,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
804,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
804,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
804,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
804,6,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
804,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
804,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
804,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
805,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
805,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
805,3,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
805,4,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
805,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
805,6,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
805,7,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
806,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
807,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
807,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
807,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
808,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
808,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
809,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
809,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
810,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
811,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
811,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
811,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
811,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
811,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
811,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
812,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
812,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
812,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
813,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
814,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
815,1,Adductor vocal cord weakness,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
815,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
815,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
815,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
815,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
815,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
815,7,Urticaria cholinergic,Urticarias,Angioedema and urticaria,Skin,N
816,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
816,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
816,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
816,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
816,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
817,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
817,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
817,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
817,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
818,1,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
818,2,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
819,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,Y
820,1,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
820,2,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
820,3,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
820,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
821,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,Y
822,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
823,1,Encephalomyelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
824,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
824,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
824,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
824,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
824,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
825,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
825,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
825,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
825,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
826,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
826,2,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
827,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
828,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
828,2,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
828,3,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
828,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
828,5,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
828,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
829,1,Atypical femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
829,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
829,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
829,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
830,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
830,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
830,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
830,4,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
830,5,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
830,6,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
830,7,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
831,1,Atypical femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
832,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
832,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
832,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
832,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
832,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
833,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
834,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
835,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
835,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
835,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
835,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
835,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
836,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
837,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
838,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
839,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
839,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
839,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
840,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
840,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
840,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
840,4,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
841,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
842,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
842,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
842,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
842,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
843,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
844,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
844,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
844,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
845,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
846,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
846,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
846,3,Intestine transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
846,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
846,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
846,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
847,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
848,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
848,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
848,3,Intestine transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
848,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
848,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
848,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
849,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
849,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
849,3,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
849,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
849,5,Visual field defect,Visual field disorders,Vision disorders,Eye,N
849,6,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
850,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
851,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
851,2,Opsoclonus myoclonus,Encephalopathies NEC,Encephalopathies,Nerv,N
852,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
852,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
852,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
852,4,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
853,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
853,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
853,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
853,4,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
854,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
855,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
856,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
856,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
856,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
856,4,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
857,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
858,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
858,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
859,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
859,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
859,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
860,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
861,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
861,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
862,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
863,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
863,2,Open globe injury,Eye injuries NEC,Injuries NEC,Inj&P,N
864,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
864,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
864,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
864,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
865,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
866,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
866,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
867,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
867,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
868,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
868,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
869,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
869,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
870,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
870,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
871,1,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
872,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
872,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
873,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
874,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
874,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
875,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
875,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
876,1,Complications of transplanted heart,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
876,2,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
877,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
877,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
877,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
877,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
878,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
878,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
879,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
879,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
880,1,Complications of transplanted heart,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
880,2,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
881,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
881,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
882,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
882,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
882,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
882,4,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
882,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
882,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
882,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
882,8,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
882,9,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
882,10,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
882,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
883,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
883,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
883,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
884,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
884,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
885,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
885,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
886,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
886,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
886,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
887,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
887,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
887,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
887,4,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
887,5,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
887,6,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
888,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
889,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
889,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
890,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
891,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
892,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
892,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,Y
893,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
893,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
893,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
894,1,Anaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
895,1,Anaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
895,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
895,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
896,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
896,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
896,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
896,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
896,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
897,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
897,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
897,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
898,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
899,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
899,2,Oral mucosal erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
900,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
901,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
902,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
902,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
903,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
903,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
903,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
904,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
904,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
905,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
906,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
906,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
907,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
907,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
908,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
908,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
908,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
909,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
909,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
909,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
909,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
909,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
909,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
910,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
910,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
910,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
910,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
910,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
911,1,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
911,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
911,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
911,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
911,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
912,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
913,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
913,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
913,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
913,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
913,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
913,6,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
913,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
913,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
913,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
913,10,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
913,11,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
913,12,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
913,13,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
914,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
915,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
916,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
916,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
916,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
916,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
916,5,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
916,6,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
916,7,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
916,8,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
917,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
918,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
918,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
918,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
919,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
919,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
920,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
921,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
921,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
922,1,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
922,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
922,3,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
922,4,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
922,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
923,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
923,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
924,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
924,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
924,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
925,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
926,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
926,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
926,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
926,4,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
926,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
926,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
927,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
927,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
927,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
927,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
927,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
927,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
927,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
928,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
929,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
930,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
930,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
930,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
930,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
930,5,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
931,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
932,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
932,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
932,3,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
932,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
932,5,Decreased vibratory sense,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
932,6,Epidural lipomatosis,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
932,7,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
932,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
932,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
932,10,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
932,11,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
932,12,Loss of proprioception,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
932,13,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
932,14,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
932,15,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
932,16,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
932,17,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
932,18,Walking aid user,Disability issues,Lifestyle issues,SocCi,N
933,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
933,2,Headache,Headaches NEC,Headaches,Nerv,N
933,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
933,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
934,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
934,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
934,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
934,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
934,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
934,6,Epiretinal membrane,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
934,7,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
934,8,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
934,9,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
934,10,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
934,11,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
934,12,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
934,13,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
934,14,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
934,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
934,16,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
934,17,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
934,18,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
935,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
935,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
935,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
935,4,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
935,5,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
935,6,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
935,7,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
935,8,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
935,9,Disseminated cytomegaloviral infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
935,10,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
935,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
935,12,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
935,13,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
935,14,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
935,15,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
935,16,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
935,17,Oesophageal rupture,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
935,18,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
935,19,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
935,20,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
935,21,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
935,22,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
935,23,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
935,24,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
935,25,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
935,26,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
935,27,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
935,28,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
935,29,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
936,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
936,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
937,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
937,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
937,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
937,4,Growth failure,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
937,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
937,6,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
938,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
938,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
938,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
938,4,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
938,5,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
938,6,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
938,7,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
938,8,Oesophageal rupture,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
938,9,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
938,10,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
938,11,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
938,12,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
938,13,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
939,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
939,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
939,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
939,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
939,5,Headache,Headaches NEC,Headaches,Nerv,N
939,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
939,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
939,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
940,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
940,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
940,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
940,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
940,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
940,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
941,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
941,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
941,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
941,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
941,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
941,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
941,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
942,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
943,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
943,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
943,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,4,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
943,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
943,6,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
943,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
944,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
944,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
944,3,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
944,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
944,5,Extramedullary haemopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
944,6,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
944,7,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
944,8,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
944,9,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
944,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
944,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
944,12,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
944,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
944,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
945,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
945,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
946,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
946,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
946,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
947,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
948,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
948,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
948,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
948,4,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
948,5,Hostility,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
948,6,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
948,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
948,8,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
948,9,Persecutory delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
948,10,Pressure of speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
948,11,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
948,12,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
949,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
949,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
950,1,Headache,Headaches NEC,Headaches,Nerv,N
950,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
951,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
951,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
951,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
951,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
951,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
951,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
951,7,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
951,8,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
951,9,Glomerulosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
951,10,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
951,11,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
951,12,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
951,13,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
951,14,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
951,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
951,16,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
951,17,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
951,18,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
951,19,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
951,20,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
952,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
953,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
953,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
953,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
954,1,Cell death,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
954,2,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
954,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
954,4,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
954,5,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
954,6,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
955,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
955,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
956,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
957,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
957,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
958,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
958,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
958,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
959,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
959,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
960,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
960,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
960,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
961,1,Viral cardiomyopathy,Viral infections NEC,Viral infectious disorders,Infec,N
962,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
962,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
963,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
963,2,Viral cardiomyopathy,Viral infections NEC,Viral infectious disorders,Infec,N
964,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
964,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
964,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
964,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
964,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
965,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
965,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
965,3,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
965,4,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
965,5,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
965,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
965,7,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
966,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
967,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
968,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
969,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,Y
969,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
969,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
969,4,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
969,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
969,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
969,7,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
969,8,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
969,9,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
969,10,Mucosal erosion,Mucosal findings abnormal,General system disorders NEC,Genrl,N
969,11,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
969,12,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
969,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
969,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
969,15,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
969,16,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
969,17,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
969,18,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
969,19,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
970,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
971,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
971,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
972,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
972,2,Bloody discharge,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
972,3,Eustachian tube disorder,Eustachian tube disorders,Middle ear disorders (excl congenital),Ear,N
972,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
972,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
972,6,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
972,7,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
972,8,Oral discharge,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
972,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
972,10,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
972,11,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
972,12,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
972,13,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
973,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
974,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
974,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
974,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
974,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
975,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
976,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
976,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
976,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
976,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
976,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
976,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
977,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
977,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
977,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
978,1,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
978,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
978,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
978,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
978,5,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
978,6,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
979,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
980,1,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
980,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
980,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
980,4,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
980,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
980,6,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
981,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
982,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
982,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
982,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
982,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
982,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
983,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
983,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
984,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
984,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
984,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
984,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
984,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
984,6,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
984,7,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
984,8,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
984,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
984,10,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
984,11,Suspiciousness,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
985,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
985,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
985,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
986,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
986,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
986,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
986,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
986,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
986,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
986,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
987,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
988,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
988,2,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
988,3,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
988,4,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
988,5,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
988,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
988,7,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
988,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
988,9,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
988,10,Mean cell haemoglobin concentration increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
988,11,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
988,12,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
988,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
988,14,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
988,15,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
988,16,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
988,17,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
989,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
989,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
989,3,Cytomegalovirus enteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
989,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
989,5,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
989,6,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
989,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
989,8,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
989,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
990,1,Haemolytic transfusion reaction,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,Y
991,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
991,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
992,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
993,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
993,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
993,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
993,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
993,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
994,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
995,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
995,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
995,3,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
995,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
996,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
996,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
996,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
996,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
996,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
996,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
996,7,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
996,8,Chronic graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
996,9,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
996,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
996,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
996,12,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
997,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
997,2,Adjusted calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
997,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
997,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
997,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
997,6,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
997,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
997,8,Globulins decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
997,9,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
997,10,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
997,11,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
997,12,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
997,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
997,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
997,15,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
997,16,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
998,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
998,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
999,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
999,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
999,3,Hostility,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
999,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
999,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
999,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1000,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1000,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1000,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1001,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1002,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1002,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1002,3,Headache,Headaches NEC,Headaches,Nerv,N
1002,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1002,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1002,6,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1003,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1004,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1004,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1004,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1004,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1004,5,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1004,6,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1004,7,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1004,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1004,9,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1004,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1005,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1005,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1005,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1006,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1006,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1006,3,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1006,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1006,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1007,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1008,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1009,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1009,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1010,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1011,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1012,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1012,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1013,1,Choroidal effusion,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1013,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1013,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1014,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1014,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1015,1,Activated partial thromboplastin time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1015,2,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1015,3,Apoptosis,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
1015,4,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1015,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1015,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1015,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1015,8,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1015,9,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1015,10,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1015,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1015,12,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1015,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1015,14,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1015,15,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1016,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1016,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1016,3,Epileptic encephalopathy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1016,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1017,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1017,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1017,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1017,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1017,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1017,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1018,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1018,2,Headache,Headaches NEC,Headaches,Nerv,N
1018,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1019,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1020,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1020,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1020,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1020,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1021,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1021,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1022,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1022,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1023,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1023,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1023,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1023,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1023,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1023,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1023,7,Eosinophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1023,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1023,9,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1023,10,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1024,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1025,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1025,2,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
1026,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1027,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1028,1,Headache,Headaches NEC,Headaches,Nerv,N
1028,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1029,1,Headache,Headaches NEC,Headaches,Nerv,N
1029,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1029,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1030,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1030,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1030,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1030,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1031,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1031,2,Cytomegalovirus enteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1031,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1031,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1031,5,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1031,6,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1031,7,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1031,8,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1032,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1033,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
1033,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1033,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1033,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1034,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1035,1,Blood catecholamines abnormal,Adrenal medulla tests,Endocrine investigations (incl sex hormones),Inv,N
1035,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
1035,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1035,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1035,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1036,1,Blood catecholamines increased,Adrenal medulla tests,Endocrine investigations (incl sex hormones),Inv,N
1036,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
1036,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1036,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1036,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1037,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1037,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1037,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1037,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1037,5,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
1037,6,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1037,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1037,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1037,9,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1037,10,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1038,1,Basilar artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1038,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1038,3,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1038,4,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1039,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1039,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1039,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1040,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1040,2,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1040,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1040,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1040,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1040,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1041,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1041,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1042,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1042,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1042,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1042,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1042,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1042,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1042,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1042,8,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1043,1,Blood catecholamines abnormal,Adrenal medulla tests,Endocrine investigations (incl sex hormones),Inv,N
1043,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
1043,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1043,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1043,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1044,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1044,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1044,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1044,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1045,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1045,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1045,3,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1046,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1046,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1046,3,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1046,4,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
1046,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1046,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1046,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1046,8,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1046,9,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1046,10,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1047,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1047,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1047,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1047,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1048,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1048,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1049,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1049,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1049,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1049,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1049,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1050,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1050,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1050,3,Headache,Headaches NEC,Headaches,Nerv,N
1050,4,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1050,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1050,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1051,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
1051,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1051,3,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1051,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1051,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1051,6,Lupus myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1051,7,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1051,8,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1051,9,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1051,10,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1051,11,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1052,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1053,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1054,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1055,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1055,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1055,3,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1055,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1055,5,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1055,6,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
1055,7,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1055,8,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1055,9,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1055,10,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1055,11,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1056,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1056,2,Brain death,Death and sudden death,Fatal outcomes,Genrl,Y
1056,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1056,4,Coma,Coma states,Neurological disorders NEC,Nerv,N
1056,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1056,6,Encephalitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1056,7,Headache,Headaches NEC,Headaches,Nerv,N
1056,8,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
1056,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1056,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1056,11,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1056,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1056,13,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1056,14,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1056,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1057,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
1057,2,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
1057,3,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1057,4,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1057,5,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1057,6,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
1057,7,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1057,8,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1057,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1057,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1057,11,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1057,12,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1058,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1058,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1058,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1058,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1058,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1059,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1059,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1059,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1059,4,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1059,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1059,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1059,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1059,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1060,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1061,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1061,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1061,3,Headache,Headaches NEC,Headaches,Nerv,N
1061,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1061,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1062,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1062,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1062,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1062,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1063,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1063,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1063,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1063,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1064,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,Y
1064,2,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1065,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1065,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1065,3,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1065,4,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1066,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1066,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1067,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1067,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1067,3,Headache,Headaches NEC,Headaches,Nerv,N
1067,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1067,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1067,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1067,7,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1068,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1068,2,Cavernous sinus thrombosis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1068,3,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1068,4,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1068,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1068,6,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1068,7,Rhinocerebral mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
1068,8,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1068,9,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1069,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1069,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1069,3,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1069,4,Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
1069,5,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1069,6,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1069,7,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1069,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1069,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1069,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1069,11,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1070,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1070,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1071,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1072,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1072,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1072,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1072,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1072,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1072,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1072,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1072,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1072,9,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1072,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1072,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1072,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1072,13,Vaccination site inflammation,Vaccination site reactions,Administration site reactions,Genrl,N
1073,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1073,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1074,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1074,2,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
1075,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1075,2,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1075,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1075,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1075,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1075,6,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1075,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1075,8,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1075,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1075,10,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1075,11,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1075,12,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
1076,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1076,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1076,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1076,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1076,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1076,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1076,7,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1076,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1076,9,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1076,10,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1076,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1077,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1077,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1077,3,Crystal nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1077,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1077,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1077,6,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1077,7,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1078,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
1078,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1079,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1079,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1080,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1080,2,Arteriovenous fistula,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
1080,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1080,4,Cavernous sinus thrombosis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1080,5,Cerebellar artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1080,6,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1080,7,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1080,8,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1080,9,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1080,10,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1080,11,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1080,12,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
1080,13,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1080,14,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1080,15,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1080,16,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1080,17,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1080,18,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1080,19,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1080,20,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1080,21,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1081,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
1081,2,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1082,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1082,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1082,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1082,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1083,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1083,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1083,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1084,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1084,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1084,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1085,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1085,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1085,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1086,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1086,2,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1086,3,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1086,4,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1086,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1086,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1086,7,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1086,8,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1086,9,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1086,10,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1086,11,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1086,12,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1086,13,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1086,14,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1086,15,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1086,16,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1086,17,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1086,18,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1086,19,Hair injury,Skin injuries NEC,Injuries NEC,Inj&P,N
1086,20,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1086,21,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
1086,22,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1086,23,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1086,24,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1086,25,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1086,26,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1086,27,Spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
1086,28,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1086,29,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1086,30,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1086,31,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1087,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1087,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1087,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1087,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1087,5,Headache,Headaches NEC,Headaches,Nerv,N
1087,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1087,7,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1088,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1088,2,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1088,3,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1088,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1089,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1090,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1090,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1090,3,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1090,4,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1090,5,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1090,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1090,7,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1090,8,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1090,9,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1090,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1090,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1090,12,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1091,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1091,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1091,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1092,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1092,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1092,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1092,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1092,5,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1093,1,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1093,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1093,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1093,4,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1093,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1094,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1095,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1096,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1097,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1097,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1097,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1098,1,Anti-NMDA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1098,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1099,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1100,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1100,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1100,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1101,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1102,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1103,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1103,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1103,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1104,1,Herpes simplex hepatitis,Herpes viral infections,Viral infectious disorders,Infec,N
1104,2,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
1105,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1105,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1106,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1107,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1108,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1108,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1108,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1108,4,Headache,Headaches NEC,Headaches,Nerv,N
1108,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1108,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1108,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1108,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1108,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1109,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1109,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1110,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1110,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1110,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1110,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1111,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1111,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1111,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1112,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1113,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1114,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1114,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1114,3,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1114,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1114,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1114,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1115,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1116,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1116,2,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1117,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1117,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1117,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1117,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1118,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1118,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1119,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1120,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1121,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1121,2,Neurogenic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1122,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1123,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1124,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1124,2,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1124,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1125,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1125,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1125,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1126,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1127,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1127,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1127,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1128,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1129,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1129,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1130,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1131,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1132,1,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1132,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1132,3,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1132,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1133,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1133,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1133,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1133,4,Sciatic nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
1134,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1134,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1134,3,Penicillium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1134,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1135,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1135,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1135,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1135,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1135,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1136,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1137,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1138,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1138,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
1139,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1139,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1139,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1139,4,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1139,5,Placenta praevia,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1139,6,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1139,7,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
1140,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1140,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1140,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1140,4,Headache,Headaches NEC,Headaches,Nerv,N
1140,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1140,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1140,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1140,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1140,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1141,1,Mantle cell lymphoma stage IV,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1141,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1141,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1142,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1143,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1143,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1144,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1144,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1144,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1144,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1144,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1145,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1145,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1145,3,Migraine,Migraine headaches,Headaches,Nerv,N
1145,4,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1145,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1145,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1145,7,Tongue biting,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1146,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1146,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1146,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1146,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1146,5,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1147,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1147,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1147,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1147,4,Migraine,Migraine headaches,Headaches,Nerv,N
1147,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1147,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1147,7,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1147,8,Tongue biting,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1147,9,Tongue haemorrhage,Tongue disorders,Tongue conditions,Gastr,N
1148,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1148,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1148,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1148,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1148,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1148,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1148,7,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1148,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1148,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1148,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1148,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1148,12,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1148,13,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1148,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1149,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1149,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1149,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1149,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1149,5,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1149,6,Headache,Headaches NEC,Headaches,Nerv,N
1149,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1149,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1149,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1149,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1149,11,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1150,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1151,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1152,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1152,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1153,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1153,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1153,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1153,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1153,5,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1153,6,PCO2 increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1154,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1154,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1154,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1154,4,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1154,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1154,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1154,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1154,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1154,9,Intensive care unit delirium,Deliria,Deliria (incl confusion),Psych,N
1154,10,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1154,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1154,12,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1154,13,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1154,14,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1154,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1154,16,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
1154,17,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1155,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1155,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1155,3,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1155,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1155,5,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1155,6,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1155,7,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1155,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1155,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1155,10,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1155,11,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1155,12,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1155,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1155,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1155,15,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1155,16,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1156,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1156,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1156,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1156,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1156,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1156,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1156,7,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1157,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1157,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1157,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1157,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1157,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1157,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1157,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1157,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1157,9,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1158,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1158,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1158,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1159,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1159,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1159,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1159,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1159,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1160,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1160,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1160,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1160,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1160,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1160,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1160,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1160,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1160,9,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1161,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1161,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1161,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1161,4,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1161,5,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1161,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1161,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1161,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1161,9,Tendon injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1161,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1162,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1162,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1162,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1162,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1162,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1162,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1162,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1162,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1163,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1163,2,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
1163,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1163,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1163,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1163,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1163,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1164,1,Haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1164,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1164,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1164,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1164,5,Polychromasia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1164,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1164,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1165,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1165,2,Migraine,Migraine headaches,Headaches,Nerv,N
1166,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1166,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1166,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1167,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1168,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1168,2,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1168,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1168,4,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1168,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1168,6,Smooth muscle antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1169,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1169,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1170,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1171,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1171,2,Infective tenosynovitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1172,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1173,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1174,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1175,1,Acute cardiac event,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
1176,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1176,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1176,3,Keratopathy,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1176,4,Prostaglandin analogue periorbitopathy,Ocular disorders NEC,Eye disorders NEC,Eye,N
1176,5,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1177,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1177,2,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
1177,3,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1178,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1178,2,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1178,3,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1178,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1179,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1179,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1179,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1180,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1180,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1180,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1180,4,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1180,5,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1180,6,Histiocytic sarcoma,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1180,7,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1180,8,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1180,9,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1180,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1181,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1181,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1182,1,B-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1182,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1182,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1182,4,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1183,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1183,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1183,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1184,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1184,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1184,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1184,4,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1184,5,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1184,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1184,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1185,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1185,2,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1185,3,Gastrointestinal oedema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1185,4,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1185,5,Mesenteric haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1185,6,Pleural adhesion,Pleural conditions NEC,Pleural disorders,Resp,N
1185,7,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
1185,8,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1185,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1185,10,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
1186,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1186,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1186,3,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1186,4,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
1186,5,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1186,6,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1186,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1186,8,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1186,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1186,10,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1186,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1186,12,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
1187,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1187,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1188,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1188,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1189,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1189,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1189,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1189,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1189,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1190,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1190,2,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1191,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1191,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1191,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1191,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1191,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1191,6,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1192,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1193,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1193,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1193,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
1194,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1194,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1194,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1194,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1194,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1194,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1194,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1195,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1195,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1195,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1195,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1195,5,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1196,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1196,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1196,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1196,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1196,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1196,6,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1197,1,Intra-ocular injection complication,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1197,2,Open globe injury,Eye injuries NEC,Injuries NEC,Inj&P,N
1198,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1198,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1198,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1198,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1198,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1198,6,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1198,7,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1198,8,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1198,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1198,10,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1198,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1198,12,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1198,13,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1198,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1198,15,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1198,16,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1198,17,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1198,18,Tongue biting,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1199,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1199,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1199,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1200,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1200,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1200,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1200,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1200,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1200,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1200,7,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1201,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1202,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1203,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1204,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1204,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1204,3,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1204,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1205,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1205,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1206,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1206,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1206,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1206,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1207,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1207,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1208,1,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1208,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1208,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1209,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1209,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1210,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1210,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
1211,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1212,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1212,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1212,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1213,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1213,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1213,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1213,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1213,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1214,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1214,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1214,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1214,4,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1214,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1214,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1214,7,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1214,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1214,9,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1214,10,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1215,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1215,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1215,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1215,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1215,5,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1215,6,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1215,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1215,8,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1215,9,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1215,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1215,11,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1215,12,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1215,13,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1216,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1216,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1216,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1217,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1218,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1218,2,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1218,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1218,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1218,5,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1218,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1218,7,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
1218,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1218,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1219,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1219,2,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1219,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1219,4,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1219,5,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
1220,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1220,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1220,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1220,4,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1220,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1220,6,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1221,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1222,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
1223,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1224,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1224,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1224,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1224,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1224,5,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
1224,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1224,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1224,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1224,9,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1224,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1224,11,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1224,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1225,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1225,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1225,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1225,4,Euthyroid sick syndrome,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1225,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1225,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1225,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1225,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1225,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1225,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1225,11,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
1225,12,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1226,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1226,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1226,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1226,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1226,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1226,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1226,7,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1226,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1226,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1226,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1226,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1226,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1227,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1227,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1227,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1227,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1227,5,Haematuria traumatic,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
1227,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1227,7,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1227,8,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1227,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1227,10,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1227,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1227,12,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1227,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1228,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1228,2,Allodynia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1228,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1228,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1228,5,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1228,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1228,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1228,8,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1228,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1228,10,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1228,11,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1228,12,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1228,13,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1228,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1228,15,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1228,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1228,17,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1228,18,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1228,19,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1228,20,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1228,21,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1228,22,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1229,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1229,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1230,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1230,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1231,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1232,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1232,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1233,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1233,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1233,3,Headache,Headaches NEC,Headaches,Nerv,N
1233,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1233,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1234,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1235,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1236,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1236,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1237,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1237,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1238,1,Acute disseminated encephalomyelitis,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1239,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1239,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1239,3,Headache,Headaches NEC,Headaches,Nerv,N
1239,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1239,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1240,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1240,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1240,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1240,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1240,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1240,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1240,7,Headache,Headaches NEC,Headaches,Nerv,N
1240,8,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1240,9,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1240,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1240,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1240,12,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1240,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1240,14,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1240,15,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1240,16,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1240,17,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1241,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1241,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1241,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1242,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1242,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1243,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1243,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1243,3,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1243,4,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1244,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1245,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1245,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1246,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1246,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1247,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1247,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1248,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1248,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
1249,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1249,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1250,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1250,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1251,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1251,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1252,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1252,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1253,1,Headache,Headaches NEC,Headaches,Nerv,N
1254,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1255,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1255,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1256,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1257,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1258,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1258,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1259,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1259,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1260,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1260,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1261,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1261,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1261,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1261,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1261,5,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1261,6,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1261,7,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
1261,8,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1261,9,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1261,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1262,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1262,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1262,3,Headache,Headaches NEC,Headaches,Nerv,N
1262,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1262,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1263,1,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1263,2,Septic arthritis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1264,1,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1264,2,Septic arthritis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1265,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1265,2,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1265,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1266,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1266,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1266,3,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1266,4,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1266,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1266,6,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1266,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1266,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1266,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1266,10,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1267,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1267,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1268,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1268,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1268,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1269,1,Administration site joint movement impairment,Administration site reactions NEC,Administration site reactions,Genrl,N
1270,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1271,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1271,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1272,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1273,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1273,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1274,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1274,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1275,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1276,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1277,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1277,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1278,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1279,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1280,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1281,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1281,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1282,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1283,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
1283,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1283,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1283,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1283,5,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1283,6,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1283,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1284,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1285,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1285,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1285,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1285,4,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1285,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1286,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1287,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1287,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1287,3,Headache,Headaches NEC,Headaches,Nerv,N
1287,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1287,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1288,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1289,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1289,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1289,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1289,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1290,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1291,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1291,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1291,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1292,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1292,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1292,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1293,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1293,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1294,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1294,2,Hypoperfusion,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1294,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1294,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1295,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1295,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1296,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1296,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1297,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1298,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1299,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1300,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1300,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1301,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1301,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1302,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1302,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1303,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1303,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1303,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1304,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1304,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1304,3,Headache,Headaches NEC,Headaches,Nerv,N
1304,4,Headache,Headaches NEC,Headaches,Nerv,N
1304,5,Sinus headache,Headaches NEC,Headaches,Nerv,N
1305,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1305,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1305,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1306,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1306,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1306,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1306,4,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1307,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1307,2,Myopathy,Myopathies,Muscle disorders,Musc,N
1308,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1308,2,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1309,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1310,1,Headache,Headaches NEC,Headaches,Nerv,N
1310,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1310,3,Migraine,Migraine headaches,Headaches,Nerv,N
1310,4,Nasal inflammation,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1310,5,Osteitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1310,6,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1310,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1311,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1311,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1311,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1311,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1311,5,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1311,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1311,7,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1311,8,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1311,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1311,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1311,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1311,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1311,13,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1312,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1312,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1312,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1312,4,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1312,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1312,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1313,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1313,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1313,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1313,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1313,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1313,6,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1313,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1313,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1313,9,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1314,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1314,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1314,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1314,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1314,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1315,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1315,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1316,1,Adrenal atrophy,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1316,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1316,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1316,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1316,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1317,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1317,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1318,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1319,1,Cholinergic syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1319,2,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1320,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1320,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1320,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1321,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1321,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1322,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1322,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1322,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1323,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1324,1,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1325,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1326,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1327,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
1328,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1329,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1330,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1330,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1331,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1331,2,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
1332,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1333,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1333,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1334,1,Complement factor abnormal,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
1334,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1335,1,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1336,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1336,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1337,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1337,2,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1337,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1337,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1337,5,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1337,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1338,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1338,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1338,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1339,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1340,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1340,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1340,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1341,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1341,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1342,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1342,2,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1342,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1343,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1343,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1344,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1345,1,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1346,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1347,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1347,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1347,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1347,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1347,5,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1348,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1349,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1349,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1350,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1350,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1350,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1350,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1350,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1351,1,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1352,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1353,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1354,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1355,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1356,1,Diabetic nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1356,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1356,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1357,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1358,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1358,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1358,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1359,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1360,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1361,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1362,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1362,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1363,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1363,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1364,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1364,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1364,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1365,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1365,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1365,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1365,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1366,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1366,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1366,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1367,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1367,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1368,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1368,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1368,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1368,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1369,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1369,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
1370,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1370,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1370,3,Prostaglandin analogue periorbitopathy,Ocular disorders NEC,Eye disorders NEC,Eye,N
1370,4,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1371,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1371,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
1372,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1372,2,Headache,Headaches NEC,Headaches,Nerv,N
1372,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1372,4,Ketosis-prone diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1372,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1373,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1374,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1374,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
1375,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1376,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1376,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1376,3,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1376,4,Headache,Headaches NEC,Headaches,Nerv,N
1376,5,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1376,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1376,7,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1376,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1376,9,Platelet factor 4,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1376,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1377,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1378,1,Diabetic nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1378,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1378,3,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1379,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1379,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1379,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1379,4,Urticaria chronic,Urticarias,Angioedema and urticaria,Skin,N
1380,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1380,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1380,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1380,4,Headache,Headaches NEC,Headaches,Nerv,N
1380,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1380,6,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1380,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1380,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1380,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1381,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1381,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1381,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1381,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1381,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1381,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1381,7,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1381,8,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1382,1,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1383,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1383,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1384,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1384,2,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
1385,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1385,2,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1386,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1386,2,Dural arteriovenous fistula,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1387,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1387,2,Dural arteriovenous fistula,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1387,3,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1387,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1388,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1389,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1390,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1390,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1390,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1391,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1391,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1391,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1391,4,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
1391,5,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1391,6,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1391,7,Tonic convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1392,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1392,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1392,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1393,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1393,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1393,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1394,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1394,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1395,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1395,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1395,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1395,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1395,5,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1395,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1395,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1395,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1395,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1395,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1396,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1396,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1397,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1397,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1397,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1398,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1398,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1398,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1399,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1399,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1399,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1400,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1400,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1400,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1401,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1402,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1402,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1402,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1402,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1402,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1403,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1403,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1404,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1405,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1405,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
1406,1,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1407,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1408,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1408,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1408,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1409,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1409,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1409,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1410,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1411,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1411,2,Dural arteriovenous fistula,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1411,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1412,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1413,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1413,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1414,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1414,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1414,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1414,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1415,1,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1415,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1415,3,X-linked lymphoproliferative syndrome,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
1416,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1417,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1418,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1418,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1419,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1419,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1419,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1419,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1420,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1420,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1420,3,Headache,Headaches NEC,Headaches,Nerv,N
1420,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1420,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1420,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1420,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1421,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1421,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1421,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1421,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1421,5,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1421,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1421,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1421,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1421,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1422,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1423,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1424,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1425,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1426,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1426,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1426,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1427,1,Familial haemophagocytic lymphohistiocytosis,Haematological disorders congenital NEC,Blood and lymphatic system disorders congenital,Cong,N
1427,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1427,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1428,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1428,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1428,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1428,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1428,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1428,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1428,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1428,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1428,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1429,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1429,2,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1430,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1430,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1430,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1430,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1430,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1430,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1431,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1431,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1431,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1432,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1433,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1433,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1434,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1435,1,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1436,1,Catastrophic reaction,Stress disorders,Anxiety disorders and symptoms,Psych,N
1436,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1436,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1436,4,Oesophageal rupture,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1437,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1438,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1438,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1439,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1440,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
1440,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1441,1,Cerebellar stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1441,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1441,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1442,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1442,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1442,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1443,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1444,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1444,2,Myopathy,Myopathies,Muscle disorders,Musc,N
1444,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1444,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1445,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1445,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1445,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1445,4,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1445,5,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1445,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1445,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1445,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1445,9,Tendon injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1446,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1446,2,Headache,Headaches NEC,Headaches,Nerv,N
1446,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1446,4,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1446,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1447,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1447,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1447,3,Eosinophilic oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1447,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1448,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1448,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1448,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1448,4,Eosinophilic oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1449,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1450,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1451,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1452,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1453,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1453,2,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1453,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1453,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1453,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1453,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1453,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1454,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1455,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1455,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1456,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1456,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1456,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1456,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1457,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1457,2,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1457,3,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
1457,4,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
1457,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1458,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1458,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1458,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1458,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1459,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
1459,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
1459,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1460,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
1460,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
1460,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1461,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1461,2,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
1461,3,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
1461,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1462,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
1462,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
1462,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1462,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1463,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1463,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1464,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1464,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
1465,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1465,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1465,3,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1465,4,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1465,5,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1465,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1465,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1465,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1465,9,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1466,1,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
1467,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1467,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1467,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1468,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1468,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1469,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1470,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1470,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1471,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1472,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1472,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1472,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1473,1,Allodynia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1474,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1474,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1474,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1475,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1475,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1475,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1475,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1475,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1475,6,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1476,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1476,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1477,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1477,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1477,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1477,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1477,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1477,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1477,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1477,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1477,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1477,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1477,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1477,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1477,13,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1477,14,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1477,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1478,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1478,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1479,1,Headache,Headaches NEC,Headaches,Nerv,N
1479,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1479,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1479,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1480,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1480,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1480,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1481,1,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1482,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1482,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1482,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1482,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1482,5,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1482,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1482,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1482,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1483,1,Headache,Headaches NEC,Headaches,Nerv,N
1483,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1483,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1483,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1484,1,Acne,Acnes,Skin appendage conditions,Skin,N
1484,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1484,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1484,4,Myopathy,Myopathies,Muscle disorders,Musc,N
1484,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1484,6,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1485,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1486,1,Acne,Acnes,Skin appendage conditions,Skin,N
1486,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1486,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1486,4,Myopathy,Myopathies,Muscle disorders,Musc,N
1486,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1486,6,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1486,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1487,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1487,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1487,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1487,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1488,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1488,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1488,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1488,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1488,5,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1489,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1489,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1490,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1491,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1492,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1493,1,Blood glucose,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1493,2,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
1493,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1493,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1494,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1495,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1496,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1496,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1497,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1497,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1498,1,Cartilage injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1498,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1498,3,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1498,4,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
1498,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1498,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1498,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1498,8,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1499,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1500,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1501,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1502,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1503,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1504,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1504,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1505,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1506,1,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1507,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1508,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1509,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1510,1,Myopathy,Myopathies,Muscle disorders,Musc,N
1511,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1511,2,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1512,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1512,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1513,1,Necrotising soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1513,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1514,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1514,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1515,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1515,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1516,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1517,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1517,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1517,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1517,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1518,1,Enterocolitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1518,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1519,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1520,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1521,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1521,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1521,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1521,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1522,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1522,2,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1522,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1522,4,Warm autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1523,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1524,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1524,2,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
1524,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1525,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1525,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1525,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1525,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1525,5,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1526,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1527,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1528,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1529,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1529,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1529,3,Toxic neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1530,1,Abscess fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1530,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1530,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1530,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1530,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1530,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1530,7,Iliac artery disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1530,8,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
1530,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1530,10,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1530,11,Renal artery perforation,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1530,12,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1531,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1532,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1532,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1532,3,Toxic neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1533,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1533,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1533,3,Toxic neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1534,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1535,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1535,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1536,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1537,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1538,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1539,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1539,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1539,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1539,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1539,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1539,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1539,7,Iliac artery disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1539,8,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
1539,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1539,10,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1539,11,Renal artery perforation,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1539,12,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1540,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1541,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1541,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1542,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1542,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1542,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1542,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1543,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1544,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1545,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1545,2,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1545,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1545,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1545,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1545,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1545,7,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1546,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1546,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1546,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1546,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1546,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1547,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1547,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1547,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1548,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1548,2,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1548,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1548,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1548,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1548,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1549,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1550,1,Anorectal malformation,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1550,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1550,3,Blood bicarbonate increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1550,4,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1550,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1550,6,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1550,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1550,8,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1550,9,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1550,10,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1550,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1550,12,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1550,13,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1550,14,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1550,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1550,16,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1550,17,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1550,18,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1550,19,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1550,20,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1550,21,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1550,22,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1550,23,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1551,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1552,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1553,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1554,1,Headache,Headaches NEC,Headaches,Nerv,N
1554,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1554,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1555,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1556,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1556,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1557,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1558,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1559,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1560,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1560,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1560,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1561,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1562,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1563,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1563,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1564,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1565,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1566,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1566,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1567,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1567,2,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1568,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1569,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1570,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1570,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1570,3,Exostosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1570,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1570,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1570,6,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1570,7,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
1570,8,Injection site muscle atrophy,Injection site reactions,Administration site reactions,Genrl,N
1570,9,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1570,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1570,11,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1570,12,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1570,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1571,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1572,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1573,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1573,2,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
1573,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1574,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1575,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1575,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1575,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1576,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1576,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1577,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1577,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1577,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1578,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1579,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1579,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1580,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1580,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1580,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1580,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1580,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1581,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1581,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1581,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1581,4,New onset refractory status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1581,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1582,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1583,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1583,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1584,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1584,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1585,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1585,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1585,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1585,4,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1585,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1586,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1586,2,Foetal dystocia,Foetal position and presentation abnormalities,Foetal complications,Preg,N
1586,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1586,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1587,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1587,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1587,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1588,1,Basal ganglia haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1588,2,Collagen disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1588,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1588,4,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1589,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1589,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1589,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1589,4,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1590,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1591,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1592,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1592,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1593,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
1593,2,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1593,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1593,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1593,5,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1593,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1593,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1593,8,Peripheral pulse decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1593,9,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1594,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
1594,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1594,3,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1595,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1596,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1597,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1597,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1598,1,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1599,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1600,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1601,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1601,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1602,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1602,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1603,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1604,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1605,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1605,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1605,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1606,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1607,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1608,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1608,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1608,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1608,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1608,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1608,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1609,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1609,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1609,3,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1609,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1609,5,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
1609,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1609,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1609,8,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1609,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1609,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1609,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1609,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1609,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1609,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1609,15,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1609,16,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1610,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1611,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1611,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1611,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1612,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1613,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1613,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1613,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1614,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1614,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1615,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1616,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1617,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1618,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1619,1,Headache,Headaches NEC,Headaches,Nerv,N
1619,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1619,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1619,4,Sleep paralysis,Abnormal sleep-related events,Sleep disturbances (incl subtypes),Nerv,N
1619,5,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1619,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1620,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1620,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1620,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1620,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1620,5,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
1621,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1621,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1621,3,Donor specific antibody present,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
1621,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1621,5,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
1622,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1623,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1623,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1624,1,Allergic oedema,Allergic conditions NEC,Allergic conditions,Immun,N
1625,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1625,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1625,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1626,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1627,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1627,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1628,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1629,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1629,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1629,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1629,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1630,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1631,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1632,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1633,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1633,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1634,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1635,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1636,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1636,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1637,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1637,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1638,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1638,2,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1639,1,Familial periodic paralysis,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
1639,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1640,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1640,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1641,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1642,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1642,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1643,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1644,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1644,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1644,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1644,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1645,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1645,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1645,3,Headache,Headaches NEC,Headaches,Nerv,N
1645,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1645,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1646,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1647,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1647,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1648,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1648,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1648,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1648,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1649,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1650,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1650,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1650,3,Pulmonary tumour thrombotic microangiopathy,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1650,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1650,5,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
1651,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1652,1,Migraine,Migraine headaches,Headaches,Nerv,N
1653,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1654,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1654,2,Thyrotoxic periodic paralysis,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1655,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1656,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1656,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1656,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1657,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1657,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1657,3,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
1658,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1658,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1659,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1660,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1661,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1661,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1662,1,Headache,Headaches NEC,Headaches,Nerv,N
1662,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1663,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1663,2,Erosive duodenitis,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1663,3,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1663,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1663,5,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
1663,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1663,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1664,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1665,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1666,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1666,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1667,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1668,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1668,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1668,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1669,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1670,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1670,2,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1670,3,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1670,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
1670,5,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1671,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1671,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1671,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1671,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1671,5,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1671,6,Brain stem infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1671,7,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1671,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1671,9,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1671,10,Iron overload,Iron excess,Iron and trace metal metabolism disorders,Metab,N
1671,11,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1671,12,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1671,13,Overchelation,Mineral related disorders NEC,Iron and trace metal metabolism disorders,Metab,N
1671,14,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1672,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1673,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1673,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1673,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1674,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1674,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1674,3,Toxic optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1675,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1676,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1676,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1676,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1676,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1677,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1677,2,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1677,3,Troponin T increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
